Table 1.

Population Characteristics

Variable characteristics	Recent	Chronic	Total
Gender, n (% of individuals)
Female	1 (1.90)	13 (28.20)	14 (14.14)
Male	52 (98.10)	33 (71.80)	85 (85.86)
Risk factor for HIV acquisition, n (% of individuals)
MSM	36 (85.71)	19 (48.72)	55 (67.90)
Heterosexual	0	3 (7.69)	3 (3.70)
Relationship with at-risk heterosexual	2 (4.76)	2 (5.13)	4 (4.94)
Endemic country	1 (2.38)	13 (33.33)	14 (17.28)
MSM/IDU	3 (7.14)	0	3 (3.70)
IDU	0	2 (5.13)	2 (2.47)
Place of birth, n (% of individuals)
Canadian	27 (65.85)	19 (48.72)	46 (57.50)
Caribbean	3 (7.32)	6 (15.38)	9 (11.25)
Europe	5 (12.20)	1 (2.56)	6 (7.50)
North Africa and Middle East	1 (2.44)	0	1 (1.25)
Sub-Saharan Africa	2 (4.83)	10 (25.64)	12 (15)
Latin, Central, and South America	4.88	2 (5.13)	4 (5)
Asia	1 (2.44)	0	1 (1.25)
Aboriginal (First Nations)	0	1 (2.56)	1 (1.25)
HIV subtype, n (% of individuals)
B	45 (83.30)	36 (75.00)	81 (79.40)
Non-B	9 (17.70)	12 (25.00)	21 (20.60)
Age, n [mean; range]	31 [18–78]	46.5 [21–77]	37 [18–78]
15–24 years	12	2	14
25–34 years	23	11	34
35–44 years	6	7	13
45–54 years	7	19	26
55–64 years	4	5	9
>64 years	1	2	3
Baseline CD4+ T cell count (cells/mm3), no. of individuals [median; range]	42 [458.5; 12–1,150]	36 [175; 5–698]	78 [375; 5–1,150]
>500	19 [710; 506–1,150]	3 [609; 580–698]	22 [700; 506–1,150)
351–500	11 [415; 390–490]	7 [420; 360–485]	18 [417.5;360–490)
201–350	8 [250; 217–320]	5 [302; 220–340]	13 [252; 217–340)
≤200	4 [185; 12–200]	21 [59; 5–196]	25 [63; 5–200]
HIV viral load (log10 copy/mL), no. of individuals [median; range]	42 [4.94; 3.43–8.20]	38 [4.76; 1.60–6.34]	80 [4.90;1.60–8.20]
>5	20 [5.53; 5–8.20]	15 [5.60; 5.15–6.34]	35 [5.60; 5–8.20]
<5	22 [4.46; 3.43–.96]	23 [4.25; 1.60–4.98]	45[4.27;1.60–4.98]

Table presents the repartition of demographic, epidemiologic, clinical, and risk factors of the study population by infection status (recent or chronic).

IDU, injecting drug user; MSM, men who have sex with men.